Lead
New research published in Annals of Internal Medicine finds that nearly half of the Centers for Disease Control and Prevention’s databases that were updated at least monthly at the start of 2025 stopped receiving timely updates by October. At the beginning of 2025 the CDC maintained 82 monthly-updated systems; by late October 38 had paused and 34 showed no entries in the prior six months. The pauses began largely in March and April 2025, shortly after the presidential transition and the confirmation of a new HHS secretary. Most of the stalled databases—about 90%—were related to vaccines, the study’s authors report.
Key Takeaways
- At the start of 2025 the CDC listed 82 databases updated at least monthly; by the end of October 38 were paused, with 34 having no new entries in six months.
- Approximately 90% of the paused databases focused on vaccination metrics, including weekly COVID-19 vaccination trackers for pregnant women and adults.
- The timeline for the unexplained pauses clusters in March–April 2025, soon after President Trump took office and Robert F. Kennedy Jr. became HHS secretary.
- HHS responded that changes reflect routine data quality and system management, not political directives, and said respiratory virus and flu reporting continue via other CDC systems.
- Public-health experts warn that gaps in timely surveillance data can impede outbreak detection, local response and measurement of vaccine coverage.
- Authors suggest possible causes including staffing cuts, budget changes, or shifting priorities at HHS; definitive causes were not established in the paper.
- Separate website edits at federal health pages—such as language about vaccines and autism—have raised additional concerns among researchers about data and messaging consistency.
Background
The CDC serves two roles during infectious-disease seasons: issuing guidance and acting as the nation’s near–real-time record-keeper for disease incidence, hospitalizations and vaccine uptake. Surveillance platforms and dashboards let public-health officials monitor trends by age, geography and risk group and thereby direct immunization campaigns and resource allocation. Over decades the agency developed multiple specialized systems—from weekly adult COVID-19 vaccination trackers to emergency-department respiratory illness logs—that are updated frequently to inform state and local decisions. Changes in update cadence or accessibility can reduce situational awareness, especially for jurisdictions that lack independent surveillance capacity.
In recent months the federal public-health landscape has experienced organizational shifts, including leadership turnover at HHS and changes to longstanding advisory committees and vaccine recommendations. Those policy and personnel shifts have coincided with edits to public-facing pages on vaccines, HIV, contraception and gender identity. Critics say such changes, coupled with apparent pauses in database updates, risk fragmenting data flows that communities and clinicians rely on. The Annals study aims to document the pattern and timing of paused systems and to prompt inquiry into causes and consequences.
Main Event
The study’s research team reviewed CDC-hosted databases that were updated monthly at the start of 2025 and tracked their activity through the end of October. They identified 82 systems with a prior monthly cadence; 38 of those showed a pause in updates, and 34 had no new entries in the previous six months. The investigators flagged that most of the stalled databases related to vaccines, citing examples such as a weekly COVID-19 vaccination monitor for pregnant women and a demographic- and regionally broken-down COVID vaccination tracker for adults—all last updated in late April 2025.
Other affected systems included surveillance of respiratory illnesses treated in emergency departments and reporting on use of monoclonal or injectable prophylaxis for respiratory syncytial virus (RSV) in infants. The pauses were not uniform: some dashboards remained accessible but lacked recent data, while others showed offline or frozen status. The authors note the timing clusters in March and April, shortly after the new administration and new HHS leadership assumed office.
The HHS spokesperson told reporters that core surveillance—such as respiratory virus activity for COVID and RSV and weekly influenza reporting via FluView—continues, and that changes to some dashboards reflect routine decisions about data quality and system management. At the same time, several public-health experts and former CDC staff interviewed by the authors cautioned that absent or delayed updates on vaccination coverage degrade the ability of local health departments to detect under-vaccinated communities and to respond quickly to outbreaks.
Analysis & Implications
Surveillance systems are a foundational public-health public good: timely, granular data lets policymakers and clinicians identify emerging hotspots and allocate limited resources. When vaccine-related datasets go stale, officials lose a near–real-time lens on coverage among critical groups—pregnant people, racial and ethnic subgroups, and geographic communities—making it harder to target interventions and to evaluate the impact of policy shifts. The study’s pattern, concentrated in vaccine trackers, raises questions about whether technical, staffing or policy choices disproportionately affected those systems.
If the pauses reflect workforce reductions or budget reallocation, the effect will be structural and potentially sustained: rebuilding data systems and reporting pipelines takes months to years. Alternately, if the pauses stem from deliberate shifts in what the agency decides to publish, the implication is political and could erode trust between federal agencies and state/local partners who depend on consistent indicator series. Either pathway increases the risk of delayed responses to outbreaks and hinders evaluation of vaccine uptake trends critical for preventing resurgences of vaccine-preventable diseases.
Internationally, gaps in US vaccination surveillance matter because the United States is a major center for vaccine development and global public-health leadership. Reduced transparency or discontinuities in domestic data streams can complicate multinational comparisons and collaborative response planning. Domestically, clinicians and professional societies—such as pediatric associations—may feel compelled to reissue guidance or maintain independent advisories to fill perceived gaps in federal reporting.
Comparison & Data
| Metric | Count |
|---|---|
| Databases updated ≥ monthly (Jan 2025) | 82 |
| Databases paused (by Oct 2025) | 38 |
| Databases with no new entries in prior 6 months | 34 |
| Paused databases related to vaccines (approx.) | ~90% |
The table above summarizes key counts reported by the authors. Contextually, many public-health surveillance systems move to less frequent updates only after a deliberate decision; abrupt pauses clustered in a short period are uncommon outside of funding interruptions or major system migrations. The researchers compared the 2025 pattern to prior years and found the timing and scale of pauses notable enough to merit inquiry by oversight bodies and partner states.
Reactions & Quotes
Public-health researchers and officials gave measured but concerned responses; below are short excerpts and the context around them.
“It’s curious that all these changes are primarily, and almost exclusively, in the area of vaccination.”
Noel Brewer, Professor of Public Health, University of North Carolina at Chapel Hill
Brewer, a co-author of the study, emphasized the concentration of paused systems on vaccine monitoring and called for clarification from agency leadership on technical and policy reasons for the gaps.
“Changes to individual dashboards or update schedules reflect routine data quality and system management decisions, not political direction.”
Andrew Nixon, HHS spokesperson
HHS framed the pauses as operational rather than political and pointed to continued reporting of respiratory viruses and influenza via established CDC platforms. The statement does not, however, identify the specific operational decisions or timelines for resuming updates.
“The evidence is damning: The administration’s antivaccine stance has interrupted the reliable flow of the data we need.”
Dr. Jeanne Marrazzo, Infectious Diseases Society of America (editorialist)
Marrazzo, writing in the same journal as the study, linked the reporting pauses to broader policy shifts she characterizes as undermining vaccine uptake and public-health protections; she also has an active legal dispute with the HHS secretary related to her dismissal from a previous federal role.
Unconfirmed
- Whether the update pauses were initiated by explicit political orders from HHS or other senior leaders is not established in the study and remains unproven.
- Precise staffing or budget cuts responsible for the paused dashboards were suggested but not confirmed with agency-level budget documents or personnel records.
- Attribution of specific CDC webpage edits (for example, language about vaccines and autism) to named individuals or offices has not been independently verified in all cases.
Bottom Line
The documented pauses in dozens of CDC-maintained, frequently updated surveillance databases—most concentrated in vaccine-related trackers—represent a significant erosion of near–real-time public-health visibility if they are not explained and promptly corrected. Local health departments, clinicians and researchers rely on these data streams to detect under-immunized communities and to respond to emerging threats; sustained gaps could delay interventions and complicate assessment of policy changes affecting vaccination.
Clarifying the operational drivers of these pauses—whether technical, staffing, budgetary or policy-driven—is essential. Transparent timelines for restoring updates, an independent review of the decision-making process, and contingency data-sharing plans with states would help restore confidence and maintain the functional integrity of national surveillance. Until such clarifications are public and dashboards resume regular updates, health systems and professional groups may need to augment federal data with their own monitoring to guide local practice and public guidance.